SUBSCRIBE
SUBSCRIBE
News   Drug Development

Data To Be Presented On Adherex Technologies Inc.'s Eniluracil At American Society of Clinical Oncology 2006 Annual Meeting

June 5, 2006 | 
1 min read
Study results further support Adherex's approach to the development of eniluracil + 5-FU
Clinical research Phase 3
MORE ON THIS TOPIC
Rocket rising moving up with growthing graph bar. Marketing time, Start up business, Business success strategy, New project. Rocket launch. Business startup concept. 3d minimal render illustration
GLP-1
Altimmune rises as GLP-1/glucagon drug curbs heavy drinking in mid-stage study
July 28, 2026
 · 
3 min read
 · 
Tristan Manalac
Laptop with envelope and document with exclamation mark on screen. Receive notification, alert message, warning, get e-mail, email, spam concepts. Flat design vector illustration
FDA
UPDATE: FDA disputes Capricor’s claims of Phase 3 success for DMD cell therapy
July 27, 2026
 · 
3 min read
 · 
Heather McKenzie
Stacked person head silhouettes. Abstract painting.
Neuroscience
MapLight’s schizophrenia pill remains in Cobenfy’s shadow after mixed Phase 2 readout
July 27, 2026
 · 
2 min read
 · 
Michael Gibney
3D Paper Cut Pair of Lung dotted with yellow tumor bacteria infection spread across on a blue background with no text. Yellow dots as virus infection in the lungs. Vector Illustration.
Business
Gossamer regains rights to lung disease asset from Chiesi after Phase 3 fail
July 27, 2026
 · 
3 min read
 · 
Gabrielle Masson